Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |